We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASEI
2176
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $604K | ﹤0.01% |
12,366
-9,265
| -43% | -$468K |
|
|
GHDX
2177
DELISTED
Genomic Health, Inc.
GHDX
| $603K | ﹤0.01% |
19,724
+2,300
| +13% | +$73.1K |
|
2178
German American Bancorp
GABC
$1.9B
| $601K | ﹤0.01% |
30,636
+1,500
| +5% | +$28.9K |
|
|
AAIC
2179
DELISTED
Arlington Asset Investment Corp.
AAIC
| $601K | ﹤0.01% |
24,994
-1,440
| -5% | -$36.6K |
|
|
ABB
2180
DELISTED
ABB Ltd
ABB
| $600K | ﹤0.01% |
28,319
+1,119
| +4% | +$23K |
|
|
TNGO
2181
DELISTED
Tangoe, Inc.
TNGO
| $600K | ﹤0.01% |
43,454
+6,225
| +17% | +$76.6K |
|
|
MCF
2182
DELISTED
Contango Oil & Gas Co.
MCF
| $598K | ﹤0.01% |
27,169
+1,200
| +5% | +$30.9K |
|
2183
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.24B
| $597K | ﹤0.01% |
32,666
+5,600
| +21% | +$89K |
|
2184
Myers Industries
MYE
$1.32B
| $597K | ﹤0.01% |
34,031
+3,900
| +13% | +$68.8K |
|
|
VASC
2185
DELISTED
Vascular Solutions Inc
VASC
| $596K | ﹤0.01% |
19,641
+5,300
| +37% | +$152K |
|
|
NTT
2186
DELISTED
Nippon Telegraph & Telephone
NTT
| $596K | ﹤0.01% |
19,347
+317
| +2% | +$9.4K |
|
|
RTEC
2187
DELISTED
Rudolph Technologies Inc
RTEC
| $595K | ﹤0.01% |
54,006
+400
| +0.7% | +$4.57K |
|
2188
MacroGenics
MGNX
$252M
| $593K | ﹤0.01% |
18,915
+3,100
| +20% | +$105K |
|
2189
Tejon Ranch
TRC
$443M
| $593K | ﹤0.01% |
23,090
+412
| +2% | +$10.3K |
|
|
ZEP
2190
DELISTED
ZEP INC COM STK (DE)
ZEP
| $593K | ﹤0.01% |
34,837
+2,500
| +8% | +$40.8K |
|
2191
Argan
AGX
$8.38B
| $592K | ﹤0.01% |
16,360
+1,400
| +9% | +$45.6K |
|
2192
TriNet
TNET
$3.18B
| $592K | ﹤0.01% |
16,810
+720
| +4% | +$24.8K |
|
2193
Hovnanian Enterprises
HOV
$806M
| $591K | ﹤0.01% |
6,643
+352
| +6% | +$31.7K |
|
|
BHR
2194
Braemar Hotels & Resorts
BHR
$142M
| $590K | ﹤0.01% |
35,556
+909
| +3% | +$15.2K |
|
|
BBOX
2195
DELISTED
Black Box Corp
BBOX
| $590K | ﹤0.01% |
28,183
+1,000
| +4% | +$21.8K |
|
|
CCRN
2196
DELISTED
Cross Country Healthcare
CCRN
| $589K | ﹤0.01% |
49,680
+3,000
| +6% | +$34.4K |
|
|
XLRN
2197
DELISTED
Acceleron Pharma
XLRN
| $589K | ﹤0.01% |
15,470
+2,700
| +21% | +$107K |
|
|
BKMU
2198
DELISTED
Bank Mutual Corp
BKMU
| $589K | ﹤0.01% |
80,509
+3,500
| +5% | +$24.5K |
|
|
SRDX
2199
DELISTED
Surmodics
SRDX
| $588K | ﹤0.01% |
22,576
+450
| +2% | +$10.7K |
|
2200
CBIZ
CBZ
$2.95B
| $587K | ﹤0.01% |
62,964
+3,200
| +5% | +$28K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.